Navigation Links
St. Jude Children's Research Hospital Doctors and Scientists Team up to Fight Childhood Cancer
Date:9/1/2010

MEMPHIS, Tenn., Sept. 1 /PRNewswire-USNewswire/ -- Survival rates overall for childhood cancer are almost 80 percent—a marked advance against a disease that was curable in only a small fraction of children 50 years ago. However, despite progress, pediatric cancer remains the leading cause of death due to disease among U.S. children older than 1 year of age.

While September is Childhood Cancer Awareness Month nationwide, at St. Jude Children's Research Hospital, the fight against this disease is a year-round mission. Doctors and scientists work together not only to improve survival rates for childhood cancer, but to develop better, safer therapies to treat the disease.

"Two major efforts define our mission. One of those is to provide the best care today for every child who comes to St. Jude," said Dr. William E. Evans, St. Jude director and CEO. "The other is to conduct research that makes treatments better tomorrow."

For its efforts, St. Jude was named the nation's top children's cancer hospital in 2010–11, receiving the best overall score summarizing quality of care in a survey from U.S. News & World Report. That ranking was based on the hospital's performance in three areas: reputation; medical outcomes such as cancer survival; and care-related indicators of quality such as the number of patients, nursing staff and other factors.

Employing a bench-to-bedside approach—one of the hospital's founding concepts—basic scientists and physicians work in tandem to translate laboratory discoveries into cures.

This pairing has notably helped St. Jude investigators improve survival rates for the most common childhood cancer—acute lymphoblastic leukemia—from 4 percent when the hospital opened, to 94 percent today.

The bench-to-bedside approach recently helped St. Jude investigators dramatically advance the survival rate for pediatric acute myeloid leukemia, a cancer of the white blood cells. Smarter use of new and existing tools and technologies, including more sensitive tests to find the handful of cancer cells that survive the first round of treatment, helped push the survival rate to 71 percent three years after diagnosis— 20 percent higher than previously reported U.S. rates.

Similar doctor-and-scientist collaborations are also responsible for recent insights into several childhood brain tumors, offering more targeted therapies to combat the diseases.

In hopes of accelerating progress against childhood cancer, St. Jude officials earlier this year announced an ambitious effort to identify the genetic changes that give rise to some of the world's deadliest childhood cancers. By decoding the genomes of more than 600 childhood cancer patients, researchers hope to identify mistakes that lead to cancer.

"We are very encouraged by the progress made to date, but we're never satisfied," Evans said. "We're focused on employing the latest technologies, new approaches to drug discovery and innovative clinical trials to push the cure rates higher."

St. Jude Children's Research Hospital

St. Jude Children's Research Hospital is internationally recognized for its pioneering research and treatment of children with cancer and other catastrophic diseases. Ranked the No. 1 pediatric cancer hospital by Parents magazine and the No. 1 children's cancer hospital by U.S. News & World Report, St. Jude is the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. St. Jude has treated children from all 50 states and from around the world, serving as a trusted resource for physicians and researchers. St. Jude has developed research protocols that helped push overall survival rates for childhood cancer from less than 20 percent when the hospital opened to almost 80 percent today. St. Jude is the national coordinating center for the Pediatric Brain Tumor Consortium and the Childhood Cancer Survivor Study. In addition to pediatric cancer research, St. Jude is also a leader in sickle cell disease research and is a globally prominent research center for influenza.

Founded in 1962 by the late entertainer Danny Thomas, St. Jude freely shares its discoveries with scientific and medical communities around the world, publishing more research articles than any other pediatric cancer research center in the United States. St. Jude treats more than 5,700 patients each year and is the only pediatric cancer research center where families never pay for treatment not covered by insurance. St. Jude is financially supported by thousands of individual donors, organizations and corporations without which the hospital's work would not be possible. In 2010, St. Jude was ranked the most trusted charity in the nation in a public survey conducted by Harris Interactive, a highly respected international polling and research firm. For more information, go to www.stjude.org.


'/>"/>
SOURCE St. Jude Children's Research Hospital
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bend Research Receives Patent for Preparing Spray-Dried Drug Dispersions Using Pressure Nozzles
2. Society of Interventional Radiology Supports Research for New M.S. Treatments
3. NeoStem Comments on Recent Court Ruling Blocking the Federal Governments Funding of Embryonic Stem Cell Research
4. Embryonic Stem Cell Research in the Toilet, According to Arthritis Treatment Center
5. Preliminary Research Results Suggest up to 70% Reduction in Dose for Positron Emission Mammography Imaging
6. International Research Team Closes In On Cause of Common Form of Muscular Dystrophy
7. Reportlinker Adds Strategic Analysis of End-user Preferences in the U.S. Stem Cell Research Tools Markets
8. CVS Caremark Behavioral Change Research Partnership Presents Ongoing Research at Center for Disease Control Symposium
9. Luminex Donates Companys First MAGPIX Multiplexing System to Papua New Guinea Institute of Medical Research
10. Medco Announces Agreement to Acquire United BioSource Corporation: A Global Medical Research and Scientific Services Leader to Advance Drug Safety and Knowledge
11. New Supercomputer Connection Speeds Genetic Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 24, 2017  Zymo Research Corp., also ... Robotics, Inc., who designs, manufactures and distributes ... that teams Zymo Research,s DNA methylation detection ... extraction products with Hamilton,s high-throughput automation platforms. ... for microbiomics and RNA isolation for use ...
(Date:3/24/2017)... , Mar. 24, 2017 Research and ... in the U.S.: Consumer Strategies" report to their offering. ... ... adults approach and treat their physical pain, emphasizing consumer survey ... groups: pain sufferers and adults who have selected illnesses/conditions strongly ...
(Date:3/24/2017)... YORK , March 24, 2017   ... leading organization within medical affairs in the pharmaceutical ... as the chair of a newly formed scientific ... board members to form the first ever medical ... For more information about the ACMA, please ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... 2017 , ... Buzzies parent company, The TouchPoint Solution’s CEO and co-founder, Vicki ... UBS’ Project Entrepreneur. Mayo will present her pitch about the lifestyle wearable devices, ... annual venture competition ignites bold ideas by providing women access to the tools, training ...
(Date:3/27/2017)... ... March 27, 2017 , ... M&S ... Certificate of Conformity for the Smart System® 20/20. CE Certification builds upon M&S's ... standards and specifications such as ANSI, ISO and proven test methods used in ...
(Date:3/27/2017)... ... March 27, 2017 , ... American ... conference coverage on veterinary medicine, announces the launch of Veterinarian’s Money Digest™, a ... with the April edition of American Veterinarian™. , “We look forward ...
(Date:3/27/2017)... ... March 27, 2017 , ... Metabolism and ... at Women’s Excellence will help patients lose weight and keep it off. , ... specialists at Women's Excellence will measure BMI, body fat composition, and Calcium and ...
(Date:3/27/2017)... ... March 27, 2017 , ... EpiGentek , a ... the recent RNA methylation “gold rush” with their established portfolio of optimized assay ... of N6-methyladenosine, or m6A , RNA methylation has received a new burst ...
Breaking Medicine News(10 mins):